The largest community for pharma industry writers and readers

JOIN 2020 TPMG ONLINE PHARMA SUMMIT

CALL FOR AUTHOR - 2020 FEATURED WRITERS

Featured

Coronavirus outbreak begins to disrupt booming China drug trials

(Reuters) - The fast-spreading coronavirus is starting to disrupt testing of experimental medicines in China, posing a threat to plans by global drugmakers that...

Life Sciences Industry Rapidly Adopting Real-World Data, but Access to Robust Data a Concern/Barrier, According to Inteliquet Survey

DOVER, Del.--(BUSINESS WIRE)--Inteliquet, a leading provider of intelligent technology, advanced insights, and expertise for clinical research, patient treatment and translational medicine, announced findings of...

Trump says U.S. has ‘shut down’ coronavirus threat; China shuns U.S. help

WASHINGTON (Reuters) - The United States has taken decisive action to protect Americans from the threat of a fast-moving coronavirus while offering help to...

Cocktail of flu, HIV drugs appears to help fight coronavirus: Thai doctors

BANGKOK (Reuters) - Thai doctors have seen success in treating severe cases of the new coronavirus with combination of medications for flu and HIV,...

Trump and Trudeau discussed coronavirus in Friday phone call

WASHINGTON (Reuters) - U.S. President Donald Trump and Canadian Prime Minister Justin Trudeau discussed their countries’ efforts to monitor, contain, and mitigate the rapidly...

“Go-to-Market”: Medical Affairs, Strategies and Timings

“Go-to-Market” in Pharma is defined as a tactical action plan, that outlines the needed steps to succeed in a new market/therapeutic area. A “Go-to-Market” strategy...

Bayer wins EU recommendation for prostate cancer drug

FRANKFURT (Reuters) - Bayer on Friday won an endorsement from the European Union’s drug regulator for its prostate cancer drug darolutamide, putting it on...

Merck’s Keytruda wins U.S. FDA approval for bladder cancer

(Reuters) - The U.S. Food and Drug Administration said on Wednesday it approved Merck & Co Inc’s Keytruda for the treatment of a type...

Field Medical Affairs In Pharma/Biotech: Effectiveness, Opportunities and Challenges

  Medical Affairs has risen very fast in the last years, becoming after an initial phase of “supporting function”, a highly crucial “leading function”, representing...

The Zeigarnik Effect – What is it and how can it help increase productivity?

As I discussed in my recent webinar on the power of habit, habits, whether conscious or subconscious, are the cause of about 40-45% of...

Merck Announces FDA Approval for ERVEBO® (Ebola Zaire Vaccine, Live)

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has...

Canadian drug distributors say no to Trump import plan

TORONTO (Reuters) - Many of Canada’s drug suppliers cannot, or will not, agree to ship cheaper prescription medicines into the United States, a new...

Recent Featured Articles

Stimwave Technologies Names Aure Bruneau Chief Executive Officer

POMPANO BEACH, Fla.--(BUSINESS WIRE)--Stimwave Technologies, Inc., a global medical device company that provides minimally invasive, MRI-compatible battery-free implantable devices to treat chronic pain, today...

ICON Signs New Service Agreement With Pfizer

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a leading global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device...

Quantzig’s Experts Reveal How Pharma Analytics is Enhancing Clinical Trial Outcomes Amidst the Major Outbreak of COVID-19

LONDON--(BUSINESS WIRE)--Quantzig, a global data analytics and advisory firm, that delivers actionable analytics solutions to resolve complex business problems has announced the completion of...

Celltrion’s COVID-19 Antiviral Treatment Enters the Next Phase of Development

INCHEON, South Korea--(BUSINESS WIRE)--Celltrion Group today announced its successful transition to the second phase of development for an antiviral treatment to fight the novel...

Novocure Provides Business Update Related to COVID-19

ST. HELIER, Jersey--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) today provided an update on its response to the global COVID-19 pandemic and an initial evaluation of the...